It sure is! Don't you wish you could be part of it, instead of being reduced to posting #$%$ on an MB for spare change?
That's pretty short-sighted, especially because TGR-1101 and TGR-1202 are already in combination trials with ibrutinib. Clearly TGTX doesn't share your view that they don't need ibrutinib.
Its phase 3 candidates are destined for relatively small and difficult markets, but there is some potential for pps appreciation if the trials are successful. Too early to know if its earlier-phase compounds will do well, but there are no obvious home runs.
frazzano took her down. You have to know that any major move on the market is all frazzano, roaring in with his 10-share big-spender lots.
At least you come by your negativity honestly. But what about the combination study of TGR-1202 and ibrutinib? PCYC and TGTX are linked!
There's only a single toxic peptide between your ears, which is why your intelligence is less than 30% of normal.
Nothing in BT surprises me. The price action toward the close telegraphed an offer lower than the current pps, so the news is not too shocking. Though a higher offer price might have indicated more confidence in CLDX's prospects.
Not much happening AH, so maybe there won't be too big a drop tomorrow.
That might happen, true. And in an ideal world, I would want PCYC to remain independent too.
But competition could also sneak in over the next few years, there could be trial setbacks, etc. so Mr. Duggan and the board have to decide if there is to be a graceful (though possibly premature) exit or whether there is to be another roll of the dice. And I'm sure there must be some temptation for Mr. Duggan to walk away with more billions to add to his holdings.
Not the worst thing. Maybe they'll sweeten the buyout price because of the stock component.
Thanks for your concern, Jim. Buyout or not buyout--who cares? PCYC is good either way.
Nothing like losing tons of money on imaginary trades. Right, jonznaholekelly? Though maybe this is less painful than having those guys in the toilet stalls beat you.
Market seems to be betting on something around $25. Insiders will probably choose something lower because it benefits them somehow.
Probably not a bad idea to take some away. When I see wild gyrations--up 17 points only to lose 7 in a flash, down 4 only to close green, up 10 but now with 6 of that gone--I think that a large haircut is right around the corner. A close over 190 would be nice today.
Weird price action the past couple of days. Yesterday drops 4 points before closing green. Today gains 10 points before dropping half of that gain in just minutes. Who's doing this?